Table 2.
Overall detection performance of initial and final contacts evaluated per cohort.
| Cohort | Initial contacts | Final contacts | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TP | FN | FP | R (%) | P (%) | F1 (%) | TP | FN | FP | R (%) | P (%) | F1 (%) | |
| CHF | 408 | 3 | 18 | 99 | 96 | 97 | 401 | 1 | 23 | 100 | 95 | 97 |
| COPD | 2,294 | 58 | 86 | 98 | 96 | 97 | 2,235 | 37 | 147 | 99 | 94 | 96 |
| MS | 2,563 | 19 | 72 | 99 | 97 | 98 | 2,518 | 12 | 95 | 100 | 96 | 98 |
| PD | 2,431 | 23 | 40 | 99 | 98 | 99 | 2,411 | 3 | 55 | 100 | 98 | 99 |
| PFF | 1,642 | 11 | 15 | 99 | 99 | 99 | 1,614 | 18 | 45 | 99 | 97 | 98 |
| HA | 3,627 | 55 | 98 | 99 | 97 | 98 | 3,568 | 20 | 141 | 99 | 96 | 98 |
CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; F1, F1 score; FN, false negative; FP, false positive; HA, healthy adults; MS, multiple sclerosis; P, precision; PD, Parkinson's disease; PFF, proximal femoral fracture; R, recall; TP, true positive.